Peter D. Kies
2019
In 2019, Peter D. Kies earned a total compensation of $1.1M as Chief Financial Officer at Inovio Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $177,833 |
---|---|
Option Awards | $216,712 |
Salary | $523,285 |
Stock Awards | $215,096 |
Other | $10,010 |
Total | $1,142,936 |
Kies received $523.3K in salary, accounting for 46% of the total pay in 2019.
Kies also received $177.8K in non-equity incentive plan, $216.7K in option awards, $215.1K in stock awards and $10K in other compensation.
Rankings
In 2019, Peter D. Kies' compensation ranked 8,662nd out of 13,971 executives tracked by ExecPay. In other words, Kies earned more than 38.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,662 | 38th |
Manufacturing | 3,437 | 40th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 451 | 46th |
Surgical, Medical, And Dental Instruments And Supplies | 269 | 50th |
Surgical and Medical Instruments and Apparatus | 172 | 51st |
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2019.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019